The systemic impact of non‐surgical treatment of peri‐implantitis with or without adjunctive systemic metronidazole: Secondary analysis of a randomized clinical trial
Clinical Oral Implants Research · 2024-12 · 35 (12) · 1519-1530
DOI: 10.1111/clr.14339 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Implants Research, online erschienen am 02.08.2024. Verfasst von Antonio Liñares und 6 weiteren Autor:innen. Beteiligte Einrichtung: Periodontology Unit, Faculty of Odontology, University of Santiago de Compostela, Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Metronidazole, Peri-Implantitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Osteology Foundation, CIBERNED - Institute of Health Carlos III - European Regional Development Fund.
Abstract (Originalsprache)
Objectives
The aim of this study was to evaluate the systemic effect of non‐surgical peri‐implantitis treatment (NSPIT) with or without the administration of systemic metronidazole.
Methods
In this secondary analysis from a previously published clinical trial (NCT03564301), peri‐implantitis patients were randomized into two groups: test, receiving NSPIT plus 500 mg of oral systemic metronidazole three times a day for 7 days ( n = 10); and control group, receiving NSPIT plus placebo ( n = 11). Serum samples were obtained at baseline, 3 and 6 months after therapy to determine levels of inflammatory biomarkers, lipid fractions and complete blood counts.
Results
Both treatment modalities produced improvements in clinical and radiographic parameters. After 6 months from NSPIT, a substantial reduction in C‐reactive protein (6.9 mg/dL; 95% CI: 3.7 to 9.9, p < .001) and low‐density lipoprotein cholesterol (21.8 mg/dL; 95% CI: −6.9 to 50.5, p = .013) as well as a modest increase in neutrophils counts (0.4 × 10 3 /μL; 95% CI: −0.4 to 1.1, p = .010) was observed in the control group while the test group showed a significant reduction of TNF‐α (110.1; 95% CI: 38.9 to 181.4, p = .004).
Conclusions
NSPIT showed a short‐term beneficial systemic effect regardless of adjunctive use of systemic metronidazole.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Periodontology Unit, Faculty of Odontology, University of Santiago de Compostela, Santiago de Compostela, Spain.
- NeuroAging Research Group, Clinical Neurosciences Research Laboratories, Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
ORCID-Profile: Antonio Liñares, Jose Dopico, Alex Pico, Tomás Sobrino
Förderung
- Osteology Foundation
- CIBERNED - Institute of Health Carlos III - European Regional Development Fund
Zitieren
APA
Liñares, A., Dopico, J., Blanco, C., Pico, A., Sobrino, T., Blanco, J., & Leira, Y. (2024). The systemic impact of non‐surgical treatment of peri‐implantitis with or without adjunctive systemic metronidazole: Secondary analysis of a randomized clinical trial. Clinical Oral Implants Research, 35(12), 1519-1530. https://doi.org/10.1111/clr.14339
Vancouver
Liñares A, Dopico J, Blanco C, Pico A, Sobrino T, Blanco J, et al. The systemic impact of non‐surgical treatment of peri‐implantitis with or without adjunctive systemic metronidazole: Secondary analysis of a randomized clinical trial. Clinical Oral Implants Research. 2024;35(12):1519-1530. doi:10.1111/clr.14339
BibTeX
@article{Liares2024,
author = {Liñares, Antonio and Dopico, Jose and Blanco, Carlota and Pico, Alex and Sobrino, Tomás and Blanco, Juan and Leira, Yago},
title = {The systemic impact of non‐surgical treatment of peri‐implantitis with or without adjunctive systemic metronidazole: Secondary analysis of a randomized clinical trial},
journal = {Clinical Oral Implants Research},
year = {2024},
volume = {35},
number = {12},
pages = {1519--1530},
doi = {10.1111/clr.14339}
}
EUVIMED